Popular Keywords
Biochemical Metabolic Pathways
Biochemistry
Bioluminescence
Biomarkers
Biomedical Engineering
Biomolecules
Correspondence to Author: Jose Luis Turabian,
Specialist in Family and Community Medicine, Health Center Santa Maria de Benquerencia, Regional Health Service of Castilla la Mancha (SESCAM), Toledo, Spain.
Commentary
The SARS-CoV-2 virus that causes covid-19 originated
in animals and transposed to people in 2019. Around
100 million people worldwide contracted COVID-19 in
2020 alone, and it claimed the lives of 2 million people.
A transcendental turning point in medical history
was reached with the rapid production of COVID-19
vaccinations in response to the pandemic’s urgency.
The public health intervention with the most impact
on preventing morbidity and mortality from infectious
illnesses has been the widespread use of vaccination in
recent centuries. The vast majority of people tolerate
vaccinations well, and the benefits of vaccination
significantly outweigh the risk of serious side events
in most individuals [1]. While adverse drug responses
(ADRs) can occur with vaccinations, just like with any
other medical procedure [2].
Every licenced vaccination is quite successful at
preventing serious COVID-19 cases. It is significant
to note that, especially among individuals aged 65
and older, the risks of hospitalisations and deaths linked to COVID-19 are significantly greater among adults who
have not had a main series and are up to date on recommended
COVID-19 vaccination. Current vaccines offer less protection against
symptomatic infection and transmission than they do against severe
disease, and their effectiveness deteriorates with time, especially
against variations that are actively circulating. As new vaccines
become available, it is crucial to stay up to date because of this [3,4].
Widespread immunisation is linked to a reduction in mortality and
a slowed spread of the pandemic [5-8]. The COVID-19 vaccination is
the best hope for limiting the spread of illness. However the negative
effects of immunisation .
The community’s and healthcare providers’ opinions of vaccine safety
are a key factor in determining vaccination rates, even if public health
officials are concerned about vaccine efficacy and effectiveness since
they affect disease control. For the more recent immunisations, this
is more obvious [1]. Contrarily, COVID-19 is an endemic infection
that will persist for generations, hence the most vulnerable should
receive priority in immunisation [10].
Because their attitudes and expertise are frequently essential to
encouraging adoption of a vaccine, all health care personnel play a
significant role in preserving public confidence in vaccines. Clinicians
need to be well aware of both common and uncommon vaccine side
effects. The explanation is that through post-licensing surveillance,
healthcare practitioners play a crucial and fundamental role in
vaccine pharmacovigilance. Only the absence of ADRs can be used to
determine the vaccine’s safety [1].
Strong pharmacovigilance systems and international coordination
of post-licensing surveillance are necessary for the widespread
administration of vaccinations, such as the COVID-19 vaccination, in
order for governments to make the best decisions and to preserve
or increase public confidence in vaccines. On the other hand, general
medical consultations are a reliable source of ADRs, particularly those
related to vaccinations. Fundamental to understanding ADRs and
preventing vaccine rejection is the GP’s involvement [11]. The ongoing
care that comes with getting to know patients is one of the benefits
of going to a general practitioner (and the correct assessment of
ADRs, avoiding the difficulties of interpreting symptoms or diseases
that are not due to medications but to psychosocial effects).
Some people’s fear of the vaccine is greater than their fear of the
coronavirus. The focus is on the rarely occurring side effects of
vaccines, despite estimates of hundreds of deaths per day from COVID-19. There is a dearth of a culture that recognises that
drugs are not risk-free and that everyone faces some level of
risk. For instance, the World Health Organization detected 760
instances of polio caused by the oral polio vaccine (an attenuated
virus) after giving it to 3,000 million children worldwide; yet, it is
estimated that it avoided 13 million cases [12].
Yet, not everyone is vehemently opposed to vaccinations, and
many may be amenable to reasoning. It’s vital to remember
that not everyone who has never received a vaccination is
against them. In the US, 14% of adults claimed they would
“absolutely not” get the vaccine as of June 2021 [13]. However a
large number of people are in a “mobile field.” A little over 16%
of individuals want the vaccine as soon as possible, but they are
delaying their own vaccination in order to observe how it affects
others (for example, for their job).
However, some people are more susceptible to COVID-19
than others, including those who are 65 years of age or older,
pregnant, have asthma, COPD, heart failure, chronic kidney
disease, chronic liver disease, chronic neurological conditions
(Parkinson’s disease, multiple sclerosis, learning disability, or
cerebral palsy), diabetes, sickle cell disease or splenectomy,
immunosuppression (AIDS, corticosteroid treatment, or
chemotherapy), or are obese.
Compliance with preventive behaviours is essential for the
management of COVID-19. Different responses to preventive
behaviours depend on an individual’s psychological make-up
and perception of danger. Perceived vulnerability is a significant
influence. Although though COVID-19 is extremely contagious,
the more recent varieties have milder symptoms and a lower
fatality rate [14]. In general, women, older folks, those with more
education, and people who have more faith in the government
are more accepting of the COVID-19 vaccine [15]. For instance,
56% of men participated in a research of college students who
were unwilling to get immunised [16]. Vaccination rates are also
significantly lower for people with serious mental illness than
for the general population.
So what should the GP do in regards to the COVID-19 vaccine? First and foremost, he or she must pay close attention to ADRs. Secondly, he or she must take advantage of his or her unique position in the health care system (continuity of care, doctor-patient relationship, patient trust in his GP, knowledge of the context) [18] to target the most vulnerable individuals and take action to persuade those who are on the fence about vaccination to change their minds. So how can one intervene to influence a patient’s perception of the COVID-19 vaccination?
Citation:
Jose Luis Turabian. The General Practitioner’s Role in COVID-19 Vaccination. Journal of Biochemistry 2024.
Journal Info
- Journal Name: Journal of Biochemistry
- Impact Factor: 1.9
- ISSN: 2995-6536
- DOI: 10.52338/job
- Short Name: JOB
- Acceptance rate: 55%
- Volume: 6 (2024)
- Submission to acceptance: 25 days
- Acceptance to publication: 10 days
OUR PUBLICATION BENEFITS
- International Reach
- Peer Review
- Rapid Publication
- Open Access
- High Visibility